000			01929 a2200589 4500
005			20250513052456.0
264		0	_c19941212
008			199412s 0 0 eng d
022			_a0269-9370
040			_aNLM _beng _cNLM
245	0	0	_aImmunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I. _h[electronic resource]
260			_bAIDS (London, England) _cJul 1994
300			_a911-21 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAntiviral Agents _xtherapeutic use
650	0	4	_aBiomarkers _xanalysis
650	0	4	_aCD4 Lymphocyte Count
650	0	4	_aCohort Studies
650	0	4	_aComorbidity
650	0	4	_aDatabases, Factual
650	0	4	_aDisease Progression
650	0	4	_aDistrict of Columbia _xepidemiology
650	0	4	_aFemale
650	0	4	_aHIV Antibodies _xblood
650	0	4	_aHIV Infections _xblood
650	0	4	_aHIV Seropositivity
650	0	4	_aHomosexuality, Male
650	0	4	_aHumans
650	0	4	_aImmunoglobulin A _xblood
650	0	4	_aItaly _xepidemiology
650	0	4	_aLife Tables
650	0	4	_aLondon _xepidemiology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNew York City _xepidemiology
650	0	4	_aOntario _xepidemiology
650	0	4	_aPrognosis
650	0	4	_aRegression Analysis
650	0	4	_aRisk
650	0	4	_aRisk Factors
650	0	4	_aScotland _xepidemiology
650	0	4	_aSex Factors
650	0	4	_aSexual Behavior
650	0	4	_aSubstance Abuse, Intravenous _xepidemiology
650	0	4	_aSurvival Analysis
650	0	4	_aTime Factors
650	0	4	_aZidovudine _xtherapeutic use
650	0	4	_abeta 2-Microglobulin _xanalysis
773	0		_tAIDS (London, England) _gvol. 8 _gno. 7 _gp. 911-21
999			_c7945431 _d7945431